Royal Bank of Canada’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Buy |
3,001
+998
| +50% | +$665 | ﹤0.01% | 6389 |
|
|
2025
Q1 | $1K | Buy |
2,003
+597
| +42% | +$298 | ﹤0.01% | 6235 |
|
|
2024
Q4 | $2K | Sell |
1,406
-6,964
| -83% | -$9.91K | ﹤0.01% | 6191 |
|
|
2024
Q3 | $15K | Buy |
8,370
+5,264
| +169% | +$9.43K | ﹤0.01% | 5728 |
|
|
2024
Q2 | $19K | Buy |
3,106
+2,506
| +418% | +$15.3K | ﹤0.01% | 5699 |
|
|
2024
Q1 | $7K | Sell |
600
-7,834
| -93% | -$91.4K | ﹤0.01% | 5860 |
|
|
2023
Q4 | $126K | Buy |
8,434
+4,754
| +129% | +$71K | ﹤0.01% | 4942 |
|
|
2023
Q3 | $17K | Sell |
3,680
-321
| -8% | -$1.48K | ﹤0.01% | 5732 |
|
|
2023
Q2 | $30K | Buy |
4,001
+2,776
| +227% | +$20.8K | ﹤0.01% | 5547 |
|
|
2023
Q1 | $5K | Sell |
1,225
-1,537
| -56% | -$6.27K | ﹤0.01% | 6159 |
|
|
2022
Q4 | $31K | Buy |
2,762
+2,501
| +958% | +$28.1K | ﹤0.01% | 5647 |
|
|
2022
Q3 | $2K | Buy |
261
+141
| +118% | +$1.08K | ﹤0.01% | 6485 |
|
|
2022
Q2 | $1K | Sell |
120
-969
| -89% | -$8.08K | ﹤0.01% | 6603 |
|
|
2022
Q1 | $18K | Sell |
1,089
-2,044
| -65% | -$33.8K | ﹤0.01% | 6164 |
|
|
2021
Q4 | $67K | Buy |
3,133
+3,025
| +2,801% | +$64.7K | ﹤0.01% | 5669 |
|
|
2021
Q3 | $8K | Buy |
108
+85
| +370% | +$6.3K | ﹤0.01% | 6499 |
|
|
2021
Q2 | $1K | Sell |
23
-1,324
| -98% | -$57.6K | ﹤0.01% | 6789 |
|
|
2021
Q1 | $99K | Buy |
1,347
+1,321
| +5,081% | +$97.1K | ﹤0.01% | 4985 |
|
|
2020
Q4 | $2K | Buy |
+26
| New | +$2K | ﹤0.01% | 6279 |
|